packageSaxagliptin

saxagliptin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Saxagliptin is a dipeptidyl peptidase-4 inhibitor used to lower blood sugar in adults with type 2 diabetes. It is authorised in the European Union and is available both alone and in fixed oral combination products with other glucose-lowering drugs.

Summary written by glm-5.3-flash from Wikidata Q3121121 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:saxagliptin
ATC codes:A10BH03
DrugBank:DB06335
PubChem CID:11243969
ChEBI:71272
Wikidata:Q3121121
formula:C18H25N3O2
molar mass:315.417 g/mol (PubChem CID 11243969)
logP:0.7 (Drugs.Common 25.09, not verified)

Metabolites

HydroxySaxagliptin55-hydroxy saxagliptin331.416 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
HydroxySaxagliptin5metabolite: 5-hydroxy saxagliptin